Cargando…

The Link between Potassium and Mild Cognitive Impairment in Mexican-Americans

BACKGROUND: Recent evidence suggests that increasing dietary intake of minerals reduces the risk of dementia. This study aimed to examine the relationship between potassium and diagnosis of mild cognitive impairment (MCI) in a sample of older Mexican-Americans from rural and urban populations. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vintimilla, Raul M., Large, Stephanie E., Gamboa, Adriana, Rohlfing, Geoffrey D., O'Jile, Judith R., Hall, James R., O'Bryant, Sid E., Johnson, Leigh A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2018
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5968281/ https://www.ncbi.nlm.nih.gov/pubmed/29805381 http://dx.doi.org/10.1159/000488483

Ejemplares similares

The relationship of CRP and cognition in cognitively normal older Mexican Americans: A cross-sectional study of the HABLE cohort
por: Vintimilla, Raul, et al.
Publicado: (2019)

Subjective cognitive complaints and cardiovascular risk factors in older Mexican Americans: A cross-sectional study.
por: Vintimilla, Raul, et al.
Publicado: (2022)

Cardiovascular Risk Factors and Cognitive Performance in Cognitively Normal Non-Hispanic Whites and Mexican Americans From the HABS-HD Cohort
por: Vintimilla, Raul, et al.
Publicado: (2022)

Cardiovascular Risk Factors, Cognitive Dysfunction, and Mild Cognitive Impairment
por: Vintimilla, Raul, et al.
Publicado: (2020)

Depression, inflammation, and memory loss among Mexican Americans: analysis of the HABLE cohort
por: Johnson, Leigh A., et al.
Publicado: (2017)

Association Between Cognitive Impairment and Chronic Kidney Disease in Mexican Americans
por: Szerlip, Harold M., et al.
Publicado: (2015)

MRI biomarkers of small vessel disease and cognition: A cross‐sectional study of a cognitively normal Mexican American cohort
por: Vintimilla, Raul, et al.
Publicado: (2021)

Depression is differentially related to cognitive and biomarker outcomes among Mexican Americans
por: O’Bryant, Sid E., et al.
Publicado: (2022)

APOEε4 Genotype Is Related to Brain Amyloid Among Mexican Americans in the HABS-HD Study
por: O'Bryant, Sid E., et al.
Publicado: (2022)

Vascular risk profile and white matter hyperintensity volume among Mexican Americans and non‐Hispanic Whites: The HABLE study
por: King, Kevin S., et al.
Publicado: (2022)

Association of Area Deprivation Index and hypertension, diabetes, dyslipidemia, and Obesity: A Cross-Sectional Study of the HABS-HD Cohort
por: Vintimilla, Raul, et al.
Publicado: (2023)

Factor structure and measurement invariance of a neuropsychological test battery designed for assessment of cognitive functioning in older Mexican Americans
por: Gavett, Brandon E., et al.
Publicado: (2018)

Factores de riesgo cardiovascular en Estados Unidos y México: comparación de los estudios HABLE y ENASEM
por: Vintimilla, Raúl, et al.
Publicado: (2020)

A Depressive Endophenotype of Mild Cognitive Impairment and Alzheimer’s Disease
por: Johnson, Leigh A., et al.
Publicado: (2013)

Circulating mitochondrial DNA: New indices of type 2 diabetes-related cognitive impairment in Mexican Americans
por: Silzer, Talisa, et al.
Publicado: (2019)

Depressive Symptom Clusters and Neuropsychological Performance in Mild Alzheimer's and Cognitively Normal Elderly
por: Hall, James R., et al.
Publicado: (2011)

A blood screening tool for detecting mild cognitive impairment and Alzheimer's disease among community‐dwelling Mexican Americans and non‐Hispanic Whites: A method for increasing representation of diverse populations in clinical research
por: O'Bryant, Sid E., et al.
Publicado: (2021)

Neurodegeneration from the AT(N) framework is different among Mexican Americans compared to non‐Hispanic Whites: A Health & Aging Brain among Latino Elders (HABLE) Study
por: O'Bryant, Sid E., et al.
Publicado: (2022)

Evaluation of Neighborhood-Level Disadvantage and Cognition in Mexican American and Non-Hispanic White Adults 50 Years and Older in the US
por: Wong, Christina G., et al.
Publicado: (2023)

Plasma Total Tau and Neurobehavioral Symptoms of Cognitive Decline in Cognitively Normal Older Adults
por: Hall, James R., et al.
Publicado: (2021)

Characterizing Plasma Biomarkers of Alzheimer's in a Diverse Community-Based Cohort: A Cross-Sectional Study of the HAB-HD Cohort
por: Hall, James R., et al.
Publicado: (2022)

Accelerating Hyperparameter Tuning in Machine Learning for Alzheimer’s Disease With High Performance Computing
por: Zhang, Fan, et al.
Publicado: (2021)

Combination of Serum and Plasma Biomarkers Could Improve Prediction Performance for Alzheimer’s Disease
por: Zhang, Fan, et al.
Publicado: (2022)

Hyperparameter Tuning with High Performance Computing Machine Learning for Imbalanced Alzheimer’s Disease Data
por: Zhang, Fan, et al.
Publicado: (2022)

Introduction to special issue on Advances in blood-based biomarkers of Alzheimer's disease
por: O'Bryant, Sid E.
Publicado: (2016)

Water T(2) as an early, global and practical biomarker for metabolic syndrome: an observational cross-sectional study
por: Robinson, Michelle D., et al.
Publicado: (2017)

Blood biomarkers for cognitive decline and clinical progression in a Mexican American cohort
por: Gonzales, Mitzi M., et al.
Publicado: (2022)

The Link between Cognitive Measures and ADLs and IADL Functioning in Mild Alzheimer's: What Has Gender Got to Do with It?
por: Hall, James R., et al.
Publicado: (2011)

Parkinson’s Disease Blood Test for Primary Care
por: O’Bryant, Sid E., et al.
Publicado: (2022)

A Precision Medicine Approach to Treating Alzheimer’s Disease Using Rosiglitazone Therapy: A Biomarker Analysis of the REFLECT Trials
por: O’Bryant, Sid E., et al.
Publicado: (2021)

Arsenic exposure, AS3MT polymorphism, and neuropsychological functioning among rural dwelling adults and elders: a cross-sectional study
por: Edwards, Melissa, et al.
Publicado: (2014)

Potential two-step proteomic signature for Parkinson's disease: Pilot analysis in the Harvard Biomarkers Study
por: O'Bryant, Sid E., et al.
Publicado: (2019)

Proteomic profiles of incident mild cognitive impairment and Alzheimer's disease among adults with Down syndrome
por: O'Bryant, Sid E., et al.
Publicado: (2020)

Molecular markers of neuropsychological functioning and Alzheimer's disease
por: Edwards, Melissa, et al.
Publicado: (2015)

Association of cardiovascular risk factors and blood biomarkers with cognition: The HABS‐HD study
por: Jiang, Xiaqing, et al.
Publicado: (2023)

Proteomic profiles of prevalent mild cognitive impairment and Alzheimer's disease among adults with Down syndrome
por: Petersen, Melissa, et al.
Publicado: (2020)

Characterizing plasma NfL in a community‐dwelling multi‐ethnic cohort: Results from the HABLE study
por: O'Bryant, Sid, et al.
Publicado: (2021)

The Health & Aging Brain among Latino Elders (HABLE) study methods and participant characteristics
por: O'Bryant, Sid E., et al.
Publicado: (2021)

The Relation between Inflammation and Neuropsychological Test Performance
por: Balldin, Valerie H., et al.
Publicado: (2012)

A blood screening test for Alzheimer's disease
por: O'Bryant, Sid E., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_5g8eq63ua1m5hd4cc0fi6hirg6